The Vicore COMPANION Study has completed recruitment in the US.

Almee™ (an investigational medical device in clinical development) is a treatment program aiming to reduce the psychological impact Pulmonary Fibrosis may have on your life. The COMPANION study results will show the effect of cognitive behavioral therapy (CBT) used on a smartphone or tablet device for reducing anxiety and increasing wellbeing in patients with Pulmonary Fibrosis.